Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration

Microbial Pathogenesis

Volumn 46, Issue 4, 2009, Pages 201-206

  Leckenby, Matthew W ^a   Spear, Abigail M ^b   Neeson, Brendan N ^b   Williamson, E Diane ^b   Cranenburgh, Rocky M ^a   Atkins, Helen S ^b  

^a Stephenson Building   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Bacillus anthracis; Haemolysin; Plasmid stabilisation; Protective antigen; Salmonella; Vaccine delivery

Indexed keywords

ANTHRAX VACCINE; BACTERIAL ANTIGEN; LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL CHROMOSOME; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENE EXPRESSION; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; OPERATOR GENE; PLASMID; PRIORITY JOURNAL; REPRESSOR GENE; SALMONELLA ENTERICA;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; FEMALE; GENETIC VECTORS; GENOMIC INSTABILITY; MICE; PLASMIDS; SALMONELLA TYPHIMURIUM; SURVIVAL ANALYSIS;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 62749102570     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.01.001     Document Type: Article

References (23)

1. Hone D.M., Shata M.T., Pascual D.W., and Lewis G.K. Mucosal vaccination with Salmonella vaccine vectors. In: Patterson Y. (Ed). Intracellular bacterial vaccine vectors: immunology, cell biology, and genetics (1999), John Wiley and Sons, London 171-222
2. Atkins H.S., Morton M., Griffin K.F., Stokes M.G.M., Nataro J.P., and Titball R.W. Recombinant Salmonella vaccines for biodefence. Vaccine 24 (2006) 2710-2717
3. Garmory H.S., Brown K.A., and Titball R.W. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 26 (2003) 339-353
4. + expression cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Biotechnology 6 (1988) 693-697
5. McNeill H.V., Sinha K.A., Hormaeche C.E., Lee J.J., and Khan C.M.A. Development of a nonantibiotic dominant marker for positively selecting expression plasmids in multivalent Salmonella vaccines. Appl Environ Microbiol 66 (2000) 1216-1219
6. Ryan E.T., Crean T.I., Kochi S.K., John M., Luciano A.A., Killeen K.P., et al. Development of a ΔglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vector strains of Vibrio cholerae. Infect Immun 68 (2000) 221-226
7. Galen J.E., Nair J., Yuang J., Wasserman S.S., Tanner M.K., Sztein M.B., et al. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun 67 (1999) 6424-6433
8. Garmory H.S., Leckenby M.W., Griffin K.F., Elvin S.J., Taylor R.R., Hartley M.G., et al. Antibiotic-free plasmid stabilisation by operator-repressor titration for vaccine delivery by using live Salmonella enterica serovar Typhimurium. Infect Immun 73 (2005) 2005-2011
9. Hone D., Attridge S., Van den Bosch L., and Hackett J. A chromosomal integration system for stabilisation of heterologous genes in Salmonella based vaccine strains. Microb Pathog 5 (1988) 407-418
10. Strugnell R.A., Maskell D., Fairweather N., Pickard D., Cockayne A., Penn C., et al. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88 (1990) 57-63
11. Strugnell R.A., Dougan G., Chatfield S., Charles I., Fairweather N., Tite J., et al. Characterisation of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordatella pertussis. Infect Immun 60 (1992) 3994-4002
12. Lee E., Platt R., Kang S., Roth J.A., and Phillips G.J. Chromosomal integration and expression of the Escherichia coli K88 gene cluster in Salmonella enterica ser. Cholerasuis strain 54. Vet Microbiol 83 (2001) 177-183
13. Schwarz S., and Liebisch B. Pulsed-field gel electrophoretic identification of Salmonella enterica serovar Typhimurium live vaccine strain Zoosaloral H. Lett Appl Microbiol 19 (1994) 469-472
14. Gentschev I., Dietrich G., and Goebel W. The E. coli α-hemolysin secretion system and its use in vaccine development. Trends Microbiol 10 (2002) 39-45
15. Bloor A.E., and Cranenburgh R.M. An efficient method of selectable marker gene excision by Xer recombination for gene replacement in bacterial chromosomes. Appl Environ Microbiol 72 (2006) 2520-2525
16. Stoker N.G., Fairweather N.F., and Spratt B.G. Versatile low-copy-number plasmid vectors for cloning in Escherichia coli. Gene 18 (1982) 335-341
17. Garmory H.S., Titball R.W., Griffin K.F., Hahn U., Böhm R., and Beyer W. Salmonella enterica serovar Typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge. Infect Immun 71 (2003) 3831-3836
18. Bullifent H.L., Griffin K.F., Jones S.M., Yates A., Harrington L., and Titball R.W. Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters. Vaccine 18 (2000) 2668-2676
19. Ryan E.T., Butterton J.R., Zhang T., Baker M.A., Stanley Jr. S.L., and Calderwood S.B. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice. Infect Immun 65 (1997) 3118-3125
20. Nelson D.L., and Kennedy E.P. Magnesium transport in Escherichia coli. Inhibition by cobaltous ion. J Biol Chem 246 (1971) 3042-3049
21. Cranenburgh R.M., Hanak J.A.J., Williams S.G., and Sherratt D.J. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res 29 (2001) E26
22. Stokes M.G.M., Titball R.W., Neeson B.N., Galen J.E., Walker N.J., Stagg A.J., et al. Oral administration of a Salmonella-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis. Infect Immun 75 (2007) 1827-1834
23. Flick-Smith H.C., Walker N.J., Gibson P., Bullifent H., Hayward S., Miller J., et al. A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect Immun 70 (2002) 1653-1656